Skip to content

TELEFLEX MEDICAL: what changed

BE 0401.993.536NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€435,178
2024 · €698,641-€263,463
Equity
€3.6m
2024 · €3.2m+€435,178
Cash
€1.5m
2024 · €1.7m-€272,783
Balance sheet total
€8.9m
2024 · €6.3m+€2.5m

Largest movements

2024 to 2025
Assets
  • Financial fixed assets +€2.9m

    up €2.9m (+5,773%), from €50,800 to €3.0m

    of which Affiliated companies: +€2.9m

  • Cash -€272,783

    down €272,783 (-15.7%), from €1.7m to €1.5m

    mainly Investment in fixed assets (net) (-€3.0m) and Contributions, distributions and other (-€0)

Equity and liabilities
  • Trade debts +€2.0m

    up €2.0m (+96.6%), from €2.0m to €4.0m

  • Profit (loss) carried forward +€435,178

    up €435,178 (+40.1%), from €1.1m to €1.5m

  • Tax, wage and social debts +€100,123

    up €100,123 (+12.1%), from €827,196 to €927,319

    of which Remuneration and social security: +€135,438

Income statement
  • Staff costs +€465,673

    up €465,673 (+23.0%), from €2.0m to €2.5m

  • Turnover +€359,552

    up €359,552 (+2.0%), from €18.3m to €18.7m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €698,641
Turnover +€359,552
Other operating income +€46,533
Goods and materials -€102,370
Services and other goods -€68,461
Staff costs -€465,673
Depreciation -€0
Write-downs -€17,593
Provisions -€667
Other operating charges -€29,533
Financial income -€72,044
Financial charges +€6,427
Taxes +€80,365
Result 2025 €435,178
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€2.7m
Investment -€3.0m
Financing -€0
Cash 2024 €1.7m
Net result for the year +€435,178
Depreciation +€37,591
Receivables within one year +€26,557
Deferred charges and accrued income +€75,971
Smaller working-capital items +€3,558
Trade debts +€2.0m
Tax, wage and social debts +€100,123
Accrued charges and deferred income +€36,912
Investment in fixed assets (net) -€3.0m
Contributions, distributions and other -€0
Cash 2025 €1.5m
brings cash intakes cash out
Every line side by side 59 lines
Line Code 2024 2025 Change %
Total assets 20/58 €6,341,228 €8,884,506 +€2.5m +40.1%
Fixed assets 21/28 €92,880 €3,011,468 +€2.9m +3,142%
Intangible fixed assets 21 €42,080 €28,053 -€14,027 -33.3%
Financial fixed assets 28 €50,800 €2,983,416 +€2.9m +5,773%
Affiliated companies 280/1 - €2,924,866 +€2.9m
Participating interests 280 - €2,924,866 +€2.9m
Other financial fixed assets 284/8 €50,800 €58,550 +€7,750 +15.3%
Amounts receivable and cash guarantees 285/8 €50,800 €58,550 +€7,750 +15.3%
Current assets 29/58 €6,248,348 €5,873,038 -€375,310 -6.0%
Stocks and contracts in progress 3 - €0 =
Amounts receivable within one year 40/41 €4,412,646 €4,386,089 -€26,557 -0.6%
Trade receivables 40 €4,362,599 €4,336,033 -€26,566 -0.6%
Other amounts receivable 41 €50,047 €50,057 +€10 0.0%
Cash at bank and in hand 54/58 €1,739,315 €1,466,532 -€272,783 -15.7%
Deferred charges and accrued income 490/1 €96,387 €20,416 -€75,971 -78.8%
Total equity and liabilities 10/49 €6,341,228 €8,884,506 +€2.5m +40.1%
Equity 10/15 €3,195,524 €3,630,702 +€435,178 +13.6%
Contributions 10/11 €707,200 €707,200 = 0.0%
Reserves 13 €1,403,501 €1,403,501 -€0 0.0%
Tax-exempt reserves 132 €22,123 €22,123 = 0.0%
Distributable reserves 133 €1,381,378 €1,381,378 -€0 0.0%
Profit (loss) carried forward 14 €1,084,823 €1,520,001 +€435,178 +40.1%
Provisions and deferred taxes 16 €5,026 €9,066 +€4,040 +80.4%
Provisions for liabilities and charges 160/5 €5,026 €9,066 +€4,040 +80.4%
Pensions and similar obligations 160 €5,026 €9,066 +€4,040 +80.4%
Amounts payable 17/49 €3,140,678 €5,244,738 +€2.1m +67.0%
Amounts payable within one year 42/48 €2,864,426 €4,931,573 +€2.1m +72.2%
Trade debts 44 €2,036,748 €4,004,255 +€2.0m +96.6%
Suppliers 440/4 €2,036,748 €4,004,255 +€2.0m +96.6%
Taxes, remuneration and social security 45 €827,196 €927,319 +€100,123 +12.1%
Taxes 450/3 €302,340 €267,025 -€35,315 -11.7%
Remuneration and social security 454/9 €524,856 €660,294 +€135,438 +25.8%
Other amounts payable 47/48 €482 €0 -€482 -100%
Accrued charges and deferred income 492/3 €276,252 €313,164 +€36,912 +13.4%
Operating income 70/76A €19,025,351 €19,431,436 +€406,085 +2.1%
Turnover 70 €18,300,462 €18,660,014 +€359,552 +2.0%
Other operating income 74 €724,889 €771,422 +€46,533 +6.4%
Operating charges 60/66A €18,142,352 €18,826,648 +€684,296 +3.8%
Goods for resale, raw materials and consumables 60 €15,299,388 €15,401,758 +€102,370 +0.7%
Purchases 600/8 €15,299,388 €15,401,758 +€102,370 +0.7%
Services and other goods 61 €777,661 €846,122 +€68,461 +8.8%
Remuneration, social security and pensions 62 €2,024,414 €2,490,087 +€465,673 +23.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €37,591 €37,591 +€0 0.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€10,079 €7,514 +€17,593
Provisions for liabilities and charges: additions (uses and reversals) 635/8 -€667 €0 +€667
Other operating charges 640/8 €14,044 €43,577 +€29,533 +210%
Operating profit (loss) 9901 €882,999 €604,788 -€278,211 -31.5%
Financial income 75/76B €90,075 €18,031 -€72,044 -80.0%
Recurring financial income 75 €90,075 €18,031 -€72,044 -80.0%
Other financial income 752/9 €90,075 €18,031 -€72,044 -80.0%
Financial charges 65/66B €15,969 €9,542 -€6,427 -40.2%
Recurring financial charges 65 €15,969 €9,542 -€6,427 -40.2%
Debt charges 650 €4,954 €1,061 -€3,893 -78.6%
Other financial charges 652/9 €11,015 €8,481 -€2,534 -23.0%
Profit (loss) for the period before taxes 9903 €957,105 €613,277 -€343,828 -35.9%
Income taxes 67/77 €258,464 €178,099 -€80,365 -31.1%
Taxes 670/3 €258,464 €178,099 -€80,365 -31.1%
Profit (loss) for the period 9904 €698,641 €435,178 -€263,463 -37.7%
Profit (loss) for the period to be appropriated 9905 €698,641 €435,178 -€263,463 -37.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€4.0m to €4.8m

Midpoint €4.3m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €3.6m
Capitalised earnings €4.3m to €6.0m
Indication €4.0m to €4.8m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€3,630,702
Intangible fixed assets (21)
-€28,053
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€3.6m

Capitalised earnings

net result for the year (9904)
2025
€435,178
2024
€698,641
2023
€675,302
2022
€680,820
2021
€629,462
Average result
€603,040
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€4.3m / €5.0m / €6.0m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.